IEML (IEML) fundamentals

IEML is a listed company, part of the Chemicals sector, listed on the NSE as IEML (ISIN INE0RRU01016). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.

What IEML does

Indian Emulsifiers Ltd is an India-based specialty chemicals company. The Company primarily manufactures a range of chemical groups, including Esterification and Transesterification products, Sulphation, Quaternization, Phosphorylation, Emulsification, Imidazolines, Wax emulsions, Amphoterics, Polymerization, Poly-quaternary compounds and various specialty emulsifiers. It manufactures, supplies and markets a diverse range of specialty chemicals to industries, such as food, cosmetic, pharmaceutical, personal care, home care, institutional and industrial cleaning, metal cleaning, metal working, lubricants, textiles, mining, oilfields, agriculture and paint and pigments. Phosphate Esters are used in the food and pharmaceutical industries and provide stability in emulsions, especially in water-based systems. Southern Emulsifiers Pty Ltd is a wholly owned subsidiary of the Company. The Company operates across nine countries. It has a manufacturing facility at MIDC LOTE.

Valuation and market data

Last close₹40.45
Market capitalisation₹47 crore
Enterprise value₹54 crore
P/E (TTM)0.00
Price to book0.58
Price to sales (TTM)0.00
Book value per share₹70.31
Dividend yield0.00%
SectorChemicals
Industry

Annual results

PeriodRevenueProfit before taxNet profitEPS
Mar 2026₹160 crore₹20 crore₹16 crore0.00
Mar 2025₹103 crore₹16 crore₹13 crore11.40
Mar 2024₹67 crore₹11 crore₹9 crore12.41

Figures are as reported (consolidated), in ₹ crore.

Shareholding pattern

As of Mar 2026:

Promoters32.6%
Foreign institutions (FII)2.0%
Mutual funds0.0%
Other domestic institutions3.3%
Retail and others62.1%

More on BreakPoint

FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.

Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.